REVITALIZING ICS + SABA THERAPY IN ASTHMA MANAGEMENT: A HIDOC DR DIGITAL CAMPAIGN CASE STUDY FROM KERALA, INDIA
Asma Shaikh Shaikh
Paper Contents
Abstract
Inhaled corticosteroids (ICS) combined with short-acting 2-agonists (SABA) are foundational in asthma management, especially following updates to the Global Initiative for Asthma (GINA) 2023 guidelines. This case study evaluates a six-month omnichannel digital campaign executed by Hidoc Dr., aimed at increasing physician awareness of Beclomethasone + Levosalbutamol therapy in Kerala. The campaign achieved a reach of 8,517 healthcare professionals (HCPs), over 533,000 impressions, and more than 30,000 clicks, maintaining a click-through rate (CTR) of 6%. This demonstrates the effectiveness of clinical education campaigns in enhancing therapeutic adherence and knowledge dissemination through digital platforms.
Copyright
Copyright © 2025 Asma Shaikh. This is an open access article distributed under the Creative Commons Attribution License.